Oramed Granted Broad Composition of Matter Patent in Europe for Oral Proteins

JERUSALEM, Oct. 31, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the European Patent Office has issued to Oramed a notice of intent to grant a patent for broader claims for its invention titled, ‘Methods and Compositions for Oral […]

Join our mailing list

Skip to content